In addition, blood was collected at day 7 for IFN-γ ICS of CD8+ T cells stimulated with tumor-specific peptides (Figure 4C), and directly compared with tumor volumes to correlate levels of CD8+ T cell activation with tumor growth (Figure 4D). This evidence concerns the gene IFNG and neoplasm.